Rubric Capital portfolio — 13F holdings Q2 2026
Rubric Capital (David Rosen) reported 84 long positions worth $10.9 billion as of 2026-06-30. Top holdings: Talen Energy Corp, FTAI Aviation Ltd., Viatris Inc, TEVA PHARMACEUTICAL INDUSTRIES LTD, GOLAR LNG LTD. Quarterly changes and source links to the original SEC 13F filings. Long options are listed separately in the interactive view.
Reported share positions (up to 20)
| Company | Report period | Value | Portfolio weight | Change | Source |
|---|---|---|---|---|---|
| Talen Energy Corp | 2026-06-30 | 1384170228.00 USD | 12.70% | hold | Original filing |
| FTAI Aviation Ltd. | 2026-06-30 | 811590000.00 USD | 7.45% | add | Original filing |
| Viatris Inc | 2026-06-30 | 542599639.00 USD | 4.98% | add | Original filing |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | 2026-06-30 | 527681000.00 USD | 4.84% | add | Original filing |
| GOLAR LNG LTD | 2026-06-30 | 457480264.00 USD | 4.20% | hold | Original filing |
| Vistra Corp. | 2026-06-30 | 284733394.00 USD | 2.61% | add | Original filing |
| TRANSALTA CORP | 2026-06-30 | 279808712.00 USD | 2.57% | add | Original filing |
| FLUOR CORP | 2026-06-30 | 262853623.00 USD | 2.41% | buy | Original filing |
| Kiniksa Pharmaceuticals International, plc | 2026-06-30 | 255787210.00 USD | 2.35% | add | Original filing |
| BGC PARTNERS, INC. | 2026-06-30 | 254422000.00 USD | 2.33% | add | Original filing |
| Zoom Communications, Inc. | 2026-06-30 | 238734237.00 USD | 2.19% | add | Original filing |
| Liberty Global Ltd. | 2026-06-30 | 235482932.00 USD | 2.16% | hold | Original filing |
| Gildan Activewear Inc. | 2026-06-30 | 232200000.00 USD | 2.13% | add | Original filing |
| Arcutis Biotherapeutics, Inc. | 2026-06-30 | 216880749.00 USD | 1.99% | hold | Original filing |
| AMAZON COM INC | 2026-06-30 | 214506000.00 USD | 1.97% | buy | Original filing |
| Roivant Sciences Ltd. | 2026-06-30 | 212340000.00 USD | 1.95% | add | Original filing |
| Zymeworks Inc. | 2026-06-30 | 182980000.00 USD | 1.68% | hold | Original filing |
| Amcor plc | 2026-06-30 | 180424001.00 USD | 1.66% | add | Original filing |
| CIMPRESS plc | 2026-06-30 | 177975000.00 USD | 1.63% | add | Original filing |
| Amneal Pharmaceuticals, Inc. | 2026-06-30 | 176019505.00 USD | 1.61% | reduce | Original filing |
Recent source filings (up to 20)
| Report period | Filed | Form | Source |
|---|---|---|---|
| 2026-06-30 | 2026-08-14 00:00:00 | 13F-HR | Original filing |
| 2026-03-31 | 2026-05-15 00:00:00 | 13F-HR | Original filing |
| 2025-12-31 | 2026-02-13 00:00:00 | 13F-HR | Original filing |
| 2025-09-30 | 2025-11-14 00:00:00 | 13F-HR | Original filing |
| 2025-06-30 | 2025-08-14 00:00:00 | 13F-HR | Original filing |
| 2025-03-31 | 2025-05-14 00:00:00 | 13F-HR | Original filing |
| 2024-12-31 | 2025-02-14 00:00:00 | 13F-HR | Original filing |
| 2024-09-30 | 2024-11-13 00:00:00 | 13F-HR | Original filing |
| 2024-06-30 | 2024-08-13 00:00:00 | 13F-HR | Original filing |
| 2024-03-31 | 2024-05-10 00:00:00 | 13F-HR | Original filing |
| 2023-12-31 | 2024-02-13 00:00:00 | 13F-HR | Original filing |
| 2023-09-30 | 2023-11-15 00:00:00 | 13F-HR/A | Original filing |
| 2023-06-30 | 2023-08-11 00:00:00 | 13F-HR | Original filing |
| 2023-03-31 | 2023-05-12 00:00:00 | 13F-HR | Original filing |
| 2022-12-31 | 2023-02-10 00:00:00 | 13F-HR | Original filing |
| 2022-09-30 | 2022-11-14 00:00:00 | 13F-HR | Original filing |
| 2022-06-30 | 2022-08-15 00:00:00 | 13F-HR/A | Original filing |
| 2022-03-31 | 2022-05-13 00:00:00 | 13F-HR | Original filing |
| 2021-12-31 | 2022-02-14 00:00:00 | 13F-HR | Original filing |
| 2021-09-30 | 2021-11-12 00:00:00 | 13F-HR | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.